BioSpace News Archive

According to Coherent Market Insights, the global radiopharmaceuticals in nuclear medicine market is estimated to be valued at US$ 6,700.5 million in 2020 and is expected to exhibit a CAGR of 8.0% over the forecast period (2020-2027). Key Trends and Analysis: Key trends in the global radiopharmaceuticals in nuclear medicine market include increasing prevalence of cancer and cardiovascular diseases, increa

Extraordinary General Meeting of Immunovia AB (publ), Corp. Reg. No. 556730-4299 was held at The Spark in Medicon Village, Scheeletorget 1, Lund, Sweden, on September 23, 2020.

To help drive continued acceleration and growth, Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, announced the creation of a new Chief Commercial Officer position, as well as other key organizational and reporting changes within the business. All of the changes are effective October 1. Salman Mir, Executive Vice President and Chief Op

- In lieu of an in-person update to the media, Dr. Theresa Tam , Canada’s Chief Public Health Officer, issued the following statement today: “There have been 146,663 cases of COVID-19 in Canada , including 9,234 deaths. 87% of people have now recovered. Over the past week, there has been a marked increase in laboratory testing, w

Mouser Electronics Inc. today released Artificial Intelligence: The Next Wave in Life Sciences, the first eBook from The Intelligent Revolution series. In the new eBook, experts from Mouser and the life science industry explore cutting-edge applications for artificial intelligence (AI) in areas such as speech therapy, flu prevention, and wildlife protection.

Magnolia Medical Technologies, Inc. today announced that the company was selected as the Innovative Technology Supplier of the Year by Vizient Inc. The award was presented in a virtual Awards Ceremony as part of the 2020 Vizient Connections Education Summit.

Verena at the Glen and Verena at the Reserve, part of the True Connection Communities (“TCC”) family, announced today that the communities have been treated with MicroShield 360’s two-step antimicrobial coating system that kills a broad spectrum of pathogens and viruses, including SARS CoV-2 (the specific coronavirus that causes COVID-19 disease), a

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced that it has filed a Clinical Trial Notification (CTN) with the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan to initiate the company’s phase 3 riGHt Trial of TransCon™ hGH (lonapegsomatropin), a long-acting prodrug of somatropin (hGH), for the treatment for pediatri

Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), today announced financial results for its fourth quarter and year ended June 30, 2020.

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its investigational neuromodulator product, DaxibotulinumtoxinA for Injection, today announced new hire grants totaling an aggregate of 23,500 inducement restricted stock awards (“RSAs”) to five employees. The RSAs vest over four years, with 25% of the underlying shares vesting on each o